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Abstract: We present a viscometric affinity biosensor that can potentially allow continuous multi-analyte monitoring 
in biological fluids like blood or plasma. The sensing principle is based on the detection of viscosity 
changes of a polymeric solution which has a selective affinity for the analyte of interest. The chemico-
mechanical sensor incorporates an actuating piezoelectric diaphragm, a sensing piezoelectric diaphragm and 
a flow-resisting microchannel for viscosity detection. A free-standing Anodic Alumina Oxide (AAO) 
porous nano-membrane is used as selective interface. A glucose-sensitive sensor was fabricated and 
extensively assessed in buffer solution. The sensor reversibility, stability and sensitivity were excellent 
during at least 65 hours. Results showed also a good degree of stability for a long term measurement (25 
days). The sensor behaviour was furthermore tested in fetal bovine serum (FBS). The obtained results for 
glucose sensing are very promising, indicating that the developed sensor is a candidate for continuous 
monitoring in biological fluids. Sensitive solutions for ionized calcium and pH are currently under 
development and should allow multi-analyte sensing in the near future. 
1 INTRODUCTION 
Continuous detection overtime of analyte levels in 
complex biological fluids such as blood or plasma is 
a tricky task since strong interferences from other 
biomolecules may occur during the measurements. 
A successful system for continuous monitoring of 
physiologically relevant parameters would afford 
great benefits in numerous pathologies such as in the 
thrombosis with the assessment of blood calcium 
levels, in diabetes with glucose concentrations or pH 
in acidosis/alkalosis disorders. In addition, these 
parameters are also of primary importance for 
critically ill patients. Today, these controls are 
performed by hand and continuous monitoring could 
contribute to reduce the risk of mortality in the 
intensive care units. 
Existing detection methods are currently based 
on electrochemical principles, which have 
limitations for in vivo monitoring. Electrochemical 
measurements depend on the analyte diffusion rate. 
Consequently, biofouling affects the sensitivity and 
frequent calibrations are required. Furthermore, the 
presence of other electrochemically active solutes 
often produces inaccuracies. An alternative approach 
which could overcome these limitations is affinity 
sensing. Affinity sensing is more tolerant to 
biofouling, which results only in an increased 
stabilization time, and is intrinsically not subjected 
to electroactive interferences. For these reasons, 
intensive investigations on affinity binding sensors 
have been carried out using different technics such 
as fluorescence (Ballerstadt, 2004) or viscosity 
measurements (Huang, 2009). Recently, hydrogel-
based sensors have emerged as promising materials 
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 for affinity sensing (Tierney, 2009). Despite many 
efforts towards the development of continuous 
biosensors for medical and biological applications, 
long term reversibility and stability remains a 
challenge. 
In this context, we propose a novel chemico-
mechanical method which aims at detecting 
viscosity changes of a solution which has a selective 
affinity for the analyte of interest (Fig. 1). A semi-
permeable membrane ensures that the analyte 
concentration in the biosensor is the same as in the 
patient blood or plasma. The viscosity detection of 
the sensitive solution is based on a microchannel 
which exhibits a resistance to the flow circulating 
through it. The sinusoidal actuation of a 
piezoelectric diaphragm generates a flow through 
the microchannel which results in a deflection of the 
sensing piezoelectric diaphragm, inducing a voltage 
which can be recorded. The phase shift between the 
applied voltage and the sensing piezoelectric 
diaphragm deflection is a measurement of the fluid 
viscosity. 
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Figure 1: Schematic illustration of the biosensor principle. 
(Cross view). 
A proof of concept of continuous glucose 
monitoring was previously reported using a 
macroscopic demonstrator (Boss, 2009). The present 
paper investigates the sensitivity, reversibility and 
reproducibility in a buffer solution of a novel 
glucose sensor fabricated by stereolithography. The 
sensor behavior in biological fluids was also 
assessed using fetal bovine serum (FBS). The 
glucose-sensitive fluid used inside the sensor was 
based on Concanavalin A (ConA), a protein which 
specifically binds to glucose, and a high-molecular-
weight dextran. When glucose concentration 
increases, dextran is partially replaced by glucose at 
the binding sites of ConA. As a result, the network 
ConA-dextran is weakened, and the viscosity of the 
sensing fluid decreases. 
2 MATERIALS AND METHODS 
2.1 Sensor Fabrication 
The sensor was fabricated by stereolithography 
using a biocompatible resin specially dedicated to 
medical applications (Proform). The actuating 
diaphragm was made up of a 50 μm thick and 3 mm 
in diameter lead zirconate titanate (PZT) disc 
(Audiowell Electronics) glued on a 10 μm thick 
brass foil (Goodfellow). The sensing diaphragm was 
made up of a 28 μm thick and 3 mm in diameter 
Polyvinylidene fluoride (PVDF) disc (Measurement 
Specialties) glued on a 10 μm thick brass foil. The 
semi-permeable membrane was a 50 μm thick 
Anodic Aluminium Oxide (AAO) membrane with 
4-6 nm in diameter pores (Synkera Technologies). A 
100×100 μm2 in section glass capillary was used as 
microchannel. The sensor assembly was realized 
using medical adhesive epoxy (Loctite M-21HP). 
The sensor was 200 μm thick and the volume of 
sensitive fluid encapsulated inside was 4 μL. The 
sensitive fluid was prepared using the protocol 
described by Kuenzi et al. (2000). The sensitive 
fluid was composed of 2% [w/w] dextran 3200 
(PSS) and 0.4% [w/w] ConA (Sigma). The viscosity 
of the sensitive fluid ranged from 5.9-16.7 mPas 
(30-2 mM glucose) at 25°C and from 4.2-9.4 mPas 
(30-2 mM) at 37°C. A low viscosity was selected to 
keep the glucose diffusion as fast as possible. 
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Figure 2: Phase shift response to multiple glucose concentrations (2, 6, 12, 20 mM). Measurement performed in reference 
solution at 25°C. 
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Figure 3: Long term glucose concentration measurement in reference solution at 37°C, between two physiologically 
relevant glucose concentrations, 2 mM and 12 mM. 
2.2 Experimental Setup 
Glucose measurements were performed in a 
reference solution which is an isotonic solution of 
the sensitive fluid, but without dextran and ConA. 
Stock solutions with different glucose concentrations 
were subsequently pumped into the test cell using a 
computer controlled syringe pump. The whole setup 
was located in a thermally regulated chamber 
(±0.01°C), as the viscosity of the sensitive fluid is 
strongly temperature dependant. 
Fetal bovine serum (FBS) was preserved frozen. 
Before use, 0.1% of sodium azide (NaN3) was added 
as preservative. FBS was heated at 56°C during 
45 min to inactivate the complement system. FBS 
was then filtered (Millex HV 0.45 μm syringe filter) 
to remove aggregates which may clog the semi-
permeable membrane. The glucose concentration of 
FBS was measured using a standard glucose meter 
(Accu-Chek). Concentrated (2M) D-glucose solution 
was added to increase the FBS glucose 
concentration. 
3 RESULTS AND DISCUSSION 
3.1 Reversibility of Glucose-induced 
Viscosity Change 
In Figure 2, a sensor is exposed successively to 
increasing and decreasing glucose concentrations (2, 
6, 12, 20 mM). Ten full cycles were performed 
during 65 hours showing an excellent reversibility 
and stability. The response time of the sensor (time 
to reach 90% of the final value) was 4.8 min for 
increasing glucose concentration and 19.3 min for 
decreasing glucose concentration. The longer time 
constant for decreasing glucose concentration is 
explained by the smaller mobility of glucose 
molecules in the viscous sensitive fluid than in the 
reference solution. The semi-permeable membrane 
porosity affects therefore more glucose molecules 
diffusing out of the sensor than glucose molecules 
entering inside the sensor. At this stage, 
miniaturization was not the primary focus and the 
response time is over the 10 min required from a 
medical point of view. The response time could be 
shorted by reducing the sensor thickness or sensitive 
fluid viscosity. The sensor sensitivity in the 
physiological and hypoglycemic ranges of glucose 
concentration (2-6 mM) was 0.1 mM, which is 
accurate enough for patients monitoring. 
3.2 Long Term Stability 
The long term stability of the sensor at 37°C was 
investigated (Fig. 3). Glucose concentrations were 
changed every 12 hours during 25 days. The sensor 
showed a remarkable stability over time, but a 
progressive loss of sensitivity was nevertheless 
observed. After 25 days, the sensor sensitivity 
dropped to 73% of the initial sensitivity. The loss of 
sensitivity was likely due to ConA leakage through 
the biggest pores and defects of the 4-6 nm pores of 
the semi-permeable membrane. We are currently 
assessing new AAO porous nano-membranes with 
reduced pores size (2-4 nm) which should improve 
the long term stability of the sensor. 
3.3 Determination of Glucose in Fetal 
Bovine Serum 
The sensor behaviour in complex biological fluids 
was evaluated using fetal bovine serum (FBS). Fig. 
4 shows the sensor response to glucose variation (2.6 
and 30 mM) in FBS at 37°C. Twelve full cycles 
were performed during 24 hours, showing a good 
stability. The response time did not increase with 
time indicating that biofouling due to protein 
adsorption on the semi-permeable membrane is not 
an issue. AAO porous nano-membranes are 
therefore well-suited as selective interface for 
biosensors intended to be used in biological fluids.  
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Figure 4: Measurement in fetal bovine serum at 37°C between 2.6 mM and 20 mM. 
The sensor sensitivity in FBS dropped to 10% of the 
sensitivity in buffer solution. After FBS testing, the 
sensor recovered its initial sensitivity in buffer 
solution. The loss of sensitivity is therefore 
reversible, which leads to the following hypothesis. 
Small glycosylated peptides may enter inside the 
sensor and competitively interfere with the binding 
reaction of ConA to glucose. This hypothesis was 
confirmed by conducting similar experiments with 
dialysed FBS. A loss of sensitivity of 30% and 40% 
were observed in 12 kDa and 3.5 kDa dialysed FBS, 
respectively. The pores size should therefore be 
significantly reduced to prevent glycosylated 
peptides from entering the sensor. We are currently 
assessing 2-4 nm AAO nano-membranes, coated 
with Al2O3 by atomic layer deposition, to minimize 
the pores size. 
4 CONCLUSIONS 
A viscosity-based affinity sensor was developed for 
continuous monitoring in biological fluids. The 
sensor was extensively tested in buffer solution, 
showing an excellent reproducibility and stability 
over 65 hours at 25°C. The sensor sensitivity 
matched well within the hypoglycemic and 
physiological ranges (2-6 mM) with a resolution of 
0.1 mM. The response time of the sensor was higher 
for decreasing glucose concentration due to the 
conjugated effect of both the reduced mobility of 
glucose molecules in the viscous sensitive solution 
and the membrane porosity. The sensor showed also 
remarkable long term stability (25 days) at 37°C. A 
limited loss of sensitivity was nevertheless observed, 
which may be explained by ConA leakage through 
defects of the AAO porous nano-membrane. In FBS, 
the response time did not increase with time, 
indicating that biofouling due to protein adsorption 
is not an issue. The sensitivity in non-dialysed and 
12 kDa dialysed FBS were 10% and 60% of the 
sensitivity in buffer solution, respectively. 
Glycosylated perptides may enter inside the sensor 
and interfere with the ConA-glucose reaction. The 
loss of sensitivity in FBS should be solved by 
reducing the membrane pores size. 
These measurements show good promise for the 
sensor to be applied as in vivo monitoring system. 
We are currently assessing Al2O3 coated 2-4 nm 
AAO nano-membranes for pores size reduction, 
which should allow sensitive measurements in FBS. 
Sensitive fluids for ionized calcium and pH are also 
under development and should allow multi-analyte 
sensing in the near future. 
REFERENCES 
Ballerstadt, R., Polak, A., Beuhler, A., Frye, J., 2004. In 
Vitro long-term performance study of a near-infrared 
fluorescence affinity sensor for glucose monitoring. 
Biosensors & Bioelectronics. Elsevier. 
Boss, C., Meurville, E., Sallese, J.M., Ryser, P., 2009. 
Novel chemico-mechanical approach towards long-
term implantable glucose sensing. Procedia 
Chemistry.  Elsevier. 
Huang, X., Li, S., Schultz, J., Wang, Q., Lin, Q., 2009. A 
MEMS affinity glucose sensor using a biocompatible 
glucose-responsive polymer. Sensor and Actuators B: 
Chemical. Elsevier. 
Huang, X., Li, S., Schultz, J., Wang, Q., Lin, Q., 2009. A 
Capacitive MEMS Viscometric Sensor for Affinity 
Detection of Glucose. J Micromech Microeng. IEEE. 
Kuenzi, S., Meurville, E., Ryser, P., 2010. Automated 
characterization of dextran/concanavalin A mixtures – 
A study of sensitivity and temperature dependence at 
low viscosity as basis for an implantable glucose 
sensor. Sensor and Actuators B: Chemical. Elsevier. 
Tierney, S., Falch, B., Hjelme, D., Stokke, B., 2009. 
Determination of Glucose Levels Using a 
Functionalized Hydrogel-Optical Fiber Biosensor: 
Toward Continuous Monitoring of Blood Glucose in 
Vivo. Anal. Chem. ACS. 
20 mM 
2.6 mM 
BIODEVICES 2011 - International Conference on Biomedical Electronics and Devices
298
